OS Therapies Incorporated (OSTX)Healthcare | Biotechnology | Grasonville, United States | NYSE American
1.39 USD
-0.01
(-0.714%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.39 Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:34 p.m. EDT
OSTX is a biotechnology stock with a significant negative valuation, as indicated by its negative forward PE, price-to-book ratio, and trailing EPS. The recent price history shows volatility and a downward trend, with the current price at $1.30, which is close to its 52-week low of $1.15. Despite some positive news, such as the potential for EU regulatory approval and recent funding, the stock's fundamentals are weak, and it has a poor cash flow position. The forecasting model suggests a slight decline in the short term, which may not be favorable for short-term traders. Long-term investors should be cautious, as the stock's fundamentals are not strong enough to justify a buy-and-hold strategy. Additionally, the lack of dividend history makes it unsuitable for income-focused investors. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.082040 |
| MSTL | 0.093855 |
| AutoETS | 0.095361 |
| AutoARIMA | 0.095362 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.30 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.814 |
| Excess Kurtosis | -0.41 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 60,624,312 |
| Forward P/E | -4.91 |
| Website | https://ostherapies.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.06040269 |
| Address1 | 115 Pullman Crossing Road |
| Address2 | Suite 103 |
| All Time High | 7.0 |
| All Time Low | 1.12 |
| Ask | 1.4 |
| Ask Size | 18,800 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 711,580 |
| Average Daily Volume3 Month | 538,718 |
| Average Volume | 538,718 |
| Average Volume10Days | 711,580 |
| Bid | 1.39 |
| Bid Size | 200 |
| Book Value | -0.164 |
| City | Grasonville |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.39 |
| Current Ratio | 0.028 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.45 |
| Day Low | 1.385 |
| Display Name | OS Therapies |
| Earnings Timestamp | 1,774,960,200 |
| Earnings Timestamp End | 1,778,761,800 |
| Earnings Timestamp Start | 1,778,761,800 |
| Ebitda | -28,342,616 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.967 |
| Enterprise Value | 55,752,060 |
| Eps Current Year | -0.43 |
| Eps Forward | -0.28333 |
| Eps Trailing Twelve Months | -0.98 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.381 |
| Fifty Day Average Change | 0.008999944 |
| Fifty Day Average Change Percent | 0.006516976 |
| Fifty Two Week Change Percent | -6.040269 |
| Fifty Two Week High | 2.57 |
| Fifty Two Week High Change | -1.18 |
| Fifty Two Week High Change Percent | -0.45914397 |
| Fifty Two Week Low | 1.15 |
| Fifty Two Week Low Change | 0.24000001 |
| Fifty Two Week Low Change Percent | 0.20869567 |
| Fifty Two Week Range | 1.15 - 2.57 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,722,519,000,000 |
| Float Shares | 31,699,323 |
| Forward Eps | -0.28333 |
| Forward P E | -4.90594 |
| Free Cashflow | -5,070,904 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.23452 |
| Held Percent Institutions | 0.04907 |
| Implied Shares Outstanding | 43,614,612 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland. |
| Long Name | OS Therapies Incorporated |
| Market | us_market |
| Market Cap | 60,624,312 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_580518990 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -28,753,844 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 60,624,309 |
| Number Of Analyst Opinions | 5 |
| Open | 1.43 |
| Operating Cashflow | -14,238,576 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 410 297 7793 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.39 |
| Post Market Time | 1,776,470,159 |
| Previous Close | 1.4 |
| Price Eps Current Year | -3.232558 |
| Price Hint | 4 |
| Price To Book | -8.47561 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.023 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.714285 |
| Regular Market Day High | 1.45 |
| Regular Market Day Low | 1.385 |
| Regular Market Day Range | 1.385 - 1.45 |
| Regular Market Open | 1.43 |
| Regular Market Previous Close | 1.4 |
| Regular Market Price | 1.39 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 765,619 |
| Return On Assets | -2.89879 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 43,614,611 |
| Shares Percent Shares Out | 0.036 |
| Shares Short | 1,366,675 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,552,122 |
| Short Name | OS Therapies Incorporated |
| Short Percent Of Float | 0.0394 |
| Short Ratio | 2.98 |
| Source Interval | 15 |
| State | MD |
| Symbol | OSTX |
| Target High Price | 20.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 10.888 |
| Target Median Price | 8.0 |
| Total Cash | 269,830 |
| Total Cash Per Share | 0.007 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.98 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.7173 |
| Two Hundred Day Average Change | -0.32730007 |
| Two Hundred Day Average Change Percent | -0.19058992 |
| Type Disp | Equity |
| Volume | 765,619 |
| Website | https://ostherapies.com |
| Zip | 21,638 |